Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02655055
Other study ID # PRO00026241
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date April 2018

Study information

Verified date March 2022
Source Versiti
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A longitudinal, randomized, controlled, single-center Phase IV clinical trial will be performed to assess changes in bone mineral density (BMD) among voluntary apheresis blood donors. The primary outcome measure will be clinically significant decline in BMD at the lumbar spine assessed by dual-energy x-ray absorptiometry (DXA).


Description:

Apheresis blood donation maximizes an individual's donation by selecting specific blood components that are used to save patient lives. Dramatic increases in the number of apheresis procedures performed each year are apparent both domestically and internationally. Apheresis requires the use of citrate anticoagulation, a substance that confers its anticoagulant effect through chelation of cations, like calcium. A small number of cross-sectional studies have reported that intermittent exposure to citrate through apheresis is associated with significant declines in donor bone mineral density (BMD). In contrast, oral potassium citrate of much lower dose has been used to treat low bone density with well-documented efficacy. The impact of citrate exposure during apheresis, either positive or negative, is important given that BMD is a significant risk factor for low trauma fracture, a problem that affects more than 2M people in the U.S. annually. It is ultimately unknown what effect repeated apheresis has on skeletal health. To address this knowledge gap, we will perform a Phase IV clinical trial of apheresis blood donors using a cross-disciplinary, multi-institutional team. As apheresis blood donation continues to affect more people, the importance of understanding the effects of repeated exposure to citrate on donor skeletal health is essential in protecting this precious community resource.


Recruitment information / eligibility

Status Completed
Enrollment 58
Est. completion date April 2018
Est. primary completion date January 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - male - eligible volunteer blood donor - = 18, and, = 65 years of age at enrollment - = 1, and, = 5 prior apheresis blood donation procedures Exclusion Criteria: - female - age < 18 or > 65 years at enrollment - ineligible for whole blood donation - BMD Z-score <(-2.0) or >(2.0) at any measurement site upon baseline assessment - metal prosthesis at measurement site - weight > 300 lbs (136 kg) - previous fracture of the lumbar spine or femoral neck - any fragility fracture, defined as a fracture resulting from a fall of standing height or less, during adulthood (specifically =18 years of age at the time of fracture) - previous lumbar spinal fusion surgery - cystic fibrosis - emphysema - celiac disease - Crohn's disease - Current or past (>1 month duration) use of medications known to affect BMD including, not limited to: (phenytoin, phenobarbital, corticosteroids) - Current Osteoporosis Medication use including, but not limited to: (Forteo, oral biphosphonates, Reclast, Prolia, calcitonin) - Unable or unwilling to donate high frequency apheresis

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
high frequency voluntary apheresis blood donation


Locations

Country Name City State
United States BloodCenter of Wisconsin Milwaukee Wisconsin

Sponsors (4)

Lead Sponsor Collaborator
Versiti Marquette University, Medical College of Wisconsin, University of Wisconsin, Milwaukee

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dual Energy XRay Absorptiometry - Total Lumbar Spine The primary outcome measure is a decline in total lumbar spine bone mineral density that exceeds the technologist's least significant change (LSC) as assessed by DXA. one year
Secondary Dual Energy XRay Absorptiometry - Femoral Neck A secondary outcome measure includes a decline in left or right femoral neck bone mineral density that exceeds the technologist's least significant change (LSC) as assessed by DXA. one year
Secondary Dual Energy XRay Absorptiometry - Total Hip A secondary outcome measure includes a decline in total hip bone mineral density that exceeds the technologist's least significant change (LSC) as assessed by DXA. one year
Secondary Dual Energy XRay Absorptiometry - Total Body Composition one year
See also
  Status Clinical Trial Phase
Completed NCT02399553 - Effect of the Interaction Between the Type of Artificial Turf and Boots Model of Bone Health in Children Soccer Players N/A
Completed NCT01059968 - Low Energy Availability, Menstrual Irregularity, and Low Bone Mass N/A
Completed NCT00838838 - Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis N/A
Not yet recruiting NCT04439097 - Effects of Multicomponent Physical Exercise Program and Mediterranean Diet in Alzheimer's Disease N/A
Active, not recruiting NCT03701789 - Effect of Baricitinib Treatment on Peripheral Bone in RA Phase 3
Completed NCT04332679 - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes N/A
Completed NCT03292146 - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study Phase 3
Not yet recruiting NCT01407458 - The Impact of a Structured Physical Activity Program on Bone Strength and Psycho-Motor Learning of Young Children N/A
Completed NCT01019122 - Longitudinal Assessment of Bone Growth in Children With Cerebral Palsy N/A
Completed NCT04203212 - BMD Alterations and Bone and Muscle Parameters During Menstrual Cessation With GnRH
Completed NCT04189718 - Comparative Evaluation of Osseodensification Versus Conventional Implant Site N/A
Terminated NCT00822159 - Influence of Bone Strength Measured by DensiProbe on Bone Related Fixation Failure N/A
Completed NCT00603551 - Screening of Bone Mineral Density in Women Who Have Received Chemotherapy
Completed NCT00420940 - The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause Phase 3
Completed NCT04029779 - Evaluation of Immediately Placed Dental Implants With Local Application of Injectable PRF in Periodontally Compromised Sites Phase 2
Completed NCT02997033 - SIBlos EXtension Study (SIBEX)
Completed NCT00809484 - Arimidex Bone Mass Index and Oral Bisphosphonates N/A
Recruiting NCT06320704 - Occlusal Balance Effect on Mandibular Bone Density by Using Fractal Analysis in Complete Denture Patients (Split-Mouth Study)
Completed NCT00473031 - The Effect of Weight Loss and Dietary Protein Intake on Bone N/A
Active, not recruiting NCT00607516 - Radiostereometric Analysis of Acetabular Wear and Periprosthetic Bone Mineral Density Changes in Hemiarthroplasties N/A